Login

RLS Global - Naventus Life Science Summit - Karin Fischer, CEO, RLS Global 00:00:00

Share On Facebook Share On Twitter

RLS Global - Naventus Life Science Summit

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Tony Fabrizi of Blue Star Capital plc announces plans to raise up to £900,000 to facilitate a strategic shift in direction.
00:10:00
Arlo Sarmiento's Journey: Building Vivant Corporation into a Powerhouse for Progress | Arlo Sarmiento, CEO, Vivant Corporation.
00:10:00
Quarterly Report: Merchant West Sanlam Collective Investments Managed Payers & Growers® Fund – Q1 2024 | Ian Anderson – Portfolio Manager
00:10:00
Employees rate Atkore International's company culture positively on Comparably.|Waltz has served as the President and Chief Executive Officer of Atkore
00:10:00
Thys van Zyl Analyzes President Ramaphosa's State of the Union Address | Thys van Zyl, CEO, Everest Wealth Management, LLC.
00:10:00
Stream of Consciousness Lyrics or Spoken Word Performance
00:10:00
Magdalena Dziczek from EKO PAK participates in the TOGETAIR 2022 event focusing on hot seats and discussions on sustainability.
00:10:00
Maximize Efficiency and Cut Costs with a Free I.T. Consultation from Computer Geeks on Call
00:10:00
Zoo Digital Group PLC announces new contract with major Hollywood studio for high-profile streaming services|Stuart Green, CEO, ZOO Digital Group plc .
00:10:00
Bigtincan Holdings Ltd assists businesses with digital sales solutions, while Cobalt Blue (ASX:COB) CEO Joe Kaderavek discusses key business drivers.
00:10:00
Interview Summary: Empress Royalties with Alex W. Sharon
00:00:00
Dr. Stephen Mcleod, CEO of the American Academy of Ophthalmology

© 2026 Nehu